![Comprehensive molecular profiles of the most common cancer types are now available. [NHGRI]](https://www.clinicalomics.com/wp-content/uploads/2019/01/74-218x150.jpeg "Tempus Gets CE Mark for its Broad-Panel Genomic Sequencing Test")
20 Molecular Diagnostics Companies to Watch
Up-and-Coming Diagnostic Test Developers Emerge as Consolidation Thins the Field.
10 Liquid Biopsy Companies in the Money
10 privately-held diagnostics developers primarily focused on liquid biopsy tests, ranked by total money raised from venture capital firms.
8 Companion Diagnostic Developers Making a Mark
If companion diagnostics (CDx) were people, they would be old enough to drink. The first CDx won FDA approval in 1998, when Dako Denmark...
10 Countries in 100K Genome Club
These ten governments have committed funding for projects that will sequence a minimum of 100,000 citizens to spur genomic medicine
Abbott Launching ID NOW COVID-19 Tests, Offering Positive Results in Five Minutes
Company expects to deliver 50,000 tests per day of the rapid, instrument-based, isothermal system designed for qualitative detection of infectious diseases.
UnitedHealthcare To Cover Genetic Testing for Precision Medicine in Depression, Anxiety
The nation’s largest private health insurer, UnitedHealthcare, announced August 1 that it will cover testing that will allow physicians to match their patients to...
Asymptomatic People Infected with SARS-CoV-2 May Have Weaker Immune Response to Virus
The researchers from Chongqing Medical University in Chongqing, China, also found that people’s antibody response to SARS-CoV-2 may diminish rapidly after infection, which may have implications for the interpretation of negative serological results.
NIH “Serosurvey” Aims to Quantify U.S. Adults with SARS-CoV-2 Antibodies
Researchers from four NIH institutes and centers plan to collect and analyze blood samples from up to 10,000 volunteers, with the aim of providing critical data for epidemiological models.
New Study Suggests COVID-19 Reinfection Unlikely
The study used four adult Chinese rhesus macaques and found that those monkeys that had been re-exposed to SARS-CoV-2, like the unexposed control monkey, showed no recurrence of COVID-19.
Small Sequencer Developer GenapSys Completes $90M Series C Financing
GenapSys’ sequencing system is about the size of an iPad, costs under $10,000, and is based on a proprietary direct electronic sequencing chip, which is intended to eliminate the need for cumbersome equipment.
